PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF MITOXANTRONE GIVEN TO PATIENTS BY INTRAPERITONEAL ADMINISTRATION

被引：0
|
作者：
ALBERTS, DS
SURWIT, EA
PENG, YM
MCCLOSKEY, T
RIVEST, R
GRAHAM, V
MCDONALD, L
ROE, D
机构：
[1] UNIV ARIZONA,COLL MED,DEPT PHARMACOL,TUCSON,AZ 85724
[2] UNIV ARIZONA,COLL MED,DEPT OBSTET & GYNECOL,TUCSON,AZ 85724
[3] UNIV ARIZONA,ARIZONA CANC CTR,PHARMACOL RES PROGRAM,TUCSON,AZ 85724
[4] AMER CYANAMID CO,MED RES DIV,PEARL RIVER,NY 10965
来源：
CANCER RESEARCH | 1988年 / 48卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：5874 / 5877
页数：4
相关论文
共 50 条
  • [21] PHASE-I PHARMACOKINETIC (PK) STUDY OF INTRAPERITONEAL (IP) THIO-TEPA (THTE)
    WADLER, S
    EGORIN, M
    ZUHOWSKI, E
    TORTORELLO, L
    SALVA, K
    WIERNIK, PH
    CLINICAL RESEARCH, 1988, 36 (05): : A803 - A803
  • [22] PHASE-I AND PHARMACOKINETIC STUDY OF HIGH-VOLUME INTRAPERITONEAL ACLACINOMYCIN-A (ACLARUBICIN)
    KERR, IG
    ARCHER, S
    DEANGELIS, C
    FARRELL, S
    HANNA, S
    MCKEE, J
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (02) : 171 - 176
  • [23] Intraperitoneal mitoxantrone: a feasibility and pharmacokinetic study
    Civalleri, D
    Vannozzi, MO
    DeCian, F
    Lunardi, G
    Steinweg, M
    Pastrone, I
    Viale, M
    Esposito, M
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (02): : 172 - 179
  • [24] A PHASE-I AND PHARMACOKINETIC STUDY OF AMPHETHINILE
    SMITH, DB
    EWEN, C
    MACKINTOSH, J
    FOX, BW
    THATCHER, N
    SCARFFE, JH
    VEZIN, R
    CROWTHER, D
    BRITISH JOURNAL OF CANCER, 1988, 57 (06) : 623 - 627
  • [25] PHASE-I AND PHARMACOKINETIC STUDY OF RHIZOXIN
    BISSETT, D
    GRAHAM, MA
    SETANOIANS, A
    CHADWICK, GA
    WILSON, P
    KOIER, I
    HENRAR, R
    SCHWARTSMANN, G
    CASSIDY, J
    KAYE, SB
    KERR, DJ
    CANCER RESEARCH, 1992, 52 (10) : 2894 - 2898
  • [26] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF THIOTEPA ADMINISTERED INTRAPERITONEALLY IN PATIENTS WITH ADVANCED MALIGNANCIES
    WADLER, S
    EGORIN, MJ
    ZUHOWSKI, EG
    TORTORELLO, L
    SALVA, K
    RUNOWICZ, CD
    WIERNIK, PH
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 132 - 139
  • [27] A PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF HEPSULFAM
    RAVDIN, PM
    HAVLIN, KA
    MARSHALL, MV
    BROWN, TD
    KOELLER, JM
    KUHN, JG
    RODRIGUEZ, G
    VONHOFF, DD
    CANCER RESEARCH, 1991, 51 (23) : 6268 - 6272
  • [28] PHASE-I STUDY AND PHARMACOKINETICS OF INTRAPERITONEAL CARBOPLATIN
    MCVIE, JG
    HUININK, WT
    DUBBELMAN, R
    FRANKLIN, H
    VANDERVIJGH, W
    KLEIN, I
    CANCER TREATMENT REVIEWS, 1985, 12 : 35 - 41
  • [29] A PHASE-I AND PHARMACOKINETIC STUDY OF INTRAVENOUS PHENYLACETATE IN PATIENTS WITH CANCER
    THIBAULT, A
    COOPER, MR
    FIGG, WD
    VENZON, DJ
    SARTOR, AO
    TOMPKINS, AC
    WEINBERGER, MS
    HEADLEE, DJ
    MCCALL, NA
    SAMID, D
    MYERS, CE
    CANCER RESEARCH, 1994, 54 (07) : 1690 - 1694
  • [30] PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF INTRAPERITONEAL CISPLATIN AND FLUOROURACIL IN PATIENTS WITH ADVANCED INTRAABDOMINAL CANCER
    SCHILSKY, RL
    CHOI, KE
    GRAYHACK, J
    GRIMMER, D
    GUARNIERI, C
    FULLEM, L
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (12) : 2054 - 2061
12345